BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 11238673)

  • 1. Regulation of experimental autoimmune encephalomyelitis in the C57BL/6J mouse by NK1.1+, DX5+, alpha beta+ T cells.
    Fritz RB; Zhao ML
    J Immunol; 2001 Mar; 166(6):4209-15. PubMed ID: 11238673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of experimental autoimmune encephalomyelitis by natural killer (NK) cells.
    Zhang B; Yamamura T; Kondo T; Fujiwara M; Tabira T
    J Exp Med; 1997 Nov; 186(10):1677-87. PubMed ID: 9362528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of V alpha 14 NK T cells.
    Pál E; Tabira T; Kawano T; Taniguchi M; Miyake S; Yamamura T
    J Immunol; 2001 Jan; 166(1):662-8. PubMed ID: 11123351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splenic NK1.1-negative, TCR alpha beta intermediate CD4+ T cells exist in naive NK1.1 allelic positive and negative mice, with the capacity to rapidly secrete large amounts of IL-4 and IFN-gamma upon primary TCR stimulation.
    Moodycliffe AM; Maiti S; Ullrich SE
    J Immunol; 1999 May; 162(9):5156-63. PubMed ID: 10227987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells.
    Lan F; Zeng D; Higuchi M; Huie P; Higgins JP; Strober S
    J Immunol; 2001 Aug; 167(4):2087-96. PubMed ID: 11489992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human invariant V alpha 24-J alpha Q TCR supports the development of CD1d-dependent NK1.1+ and NK1.1- T cells in transgenic mice.
    Capone M; Cantarella D; Schümann J; Naidenko OV; Garavaglia C; Beermann F; Kronenberg M; Dellabona P; MacDonald HR; Casorati G
    J Immunol; 2003 Mar; 170(5):2390-8. PubMed ID: 12594262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and relapsing experimental autoimmune encephalomyelitis in IL-4- and alpha/beta T cell-deficient C57BL/6 mice.
    Zhao ML; Fritz RB
    J Neuroimmunol; 1998 Jul; 87(1-2):171-8. PubMed ID: 9670859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the complementarity-determining region 3 (CDR3) of the TCR-beta chains associated with the V alpha 14 semi-invariant TCR alpha-chain in the selection of CD4+ NK T Cells.
    Ronet C; Mempel M; Thieblemont N; Lehuen A; Kourilsky P; Gachelin G
    J Immunol; 2001 Feb; 166(3):1755-62. PubMed ID: 11160221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulatory role of peritoneal NK1.1+ alpha beta T cells in IL-12 production during Salmonella infection.
    Naiki Y; Nishimura H; Kawano T; Tanaka Y; Itohara S; Taniguchi M; Yoshikai Y
    J Immunol; 1999 Aug; 163(4):2057-63. PubMed ID: 10438944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stringent V beta requirement for the development of NK1.1+ T cell receptor-alpha/beta+ cells in mouse liver.
    Ohteki T; MacDonald HR
    J Exp Med; 1996 Mar; 183(3):1277-82. PubMed ID: 8642272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice.
    Mars LT; Laloux V; Goude K; Desbois S; Saoudi A; Van Kaer L; Lassmann H; Herbelin A; Lehuen A; Liblau RS
    J Immunol; 2002 Jun; 168(12):6007-11. PubMed ID: 12055208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Control of NKT cell differentiation by tissue-specific microenvironments.
    Yang Y; Ueno A; Bao M; Wang Z; Im JS; Porcelli S; Yoon JW
    J Immunol; 2003 Dec; 171(11):5913-20. PubMed ID: 14634102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A NK1.1+ thymocyte-derived TCR beta-chain transgene promotes positive selection of thymic NK1.1+ alpha beta T cells.
    Viret C; Lantz O; He X; Bendelac A; Janeway CA
    J Immunol; 2000 Sep; 165(6):3004-14. PubMed ID: 10975809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen.
    Hameg A; Apostolou I; Leite-De-Moraes M; Gombert JM; Garcia C; Koezuka Y; Bach JF; Herbelin A
    J Immunol; 2000 Nov; 165(9):4917-26. PubMed ID: 11046017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD1d-specific NK1.1+ T cells with a transgenic variant TCR.
    Sköld M; Faizunnessa NN; Wang CR; Cardell S
    J Immunol; 2000 Jul; 165(1):168-74. PubMed ID: 10861049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfer of severe experimental autoimmune encephalomyelitis by IL-12- and IL-18-potentiated T cells is estrogen sensitive.
    Ito A; Matejuk A; Hopke C; Drought H; Dwyer J; Zamora A; Subramanian S; Vandenbark AA; Offner H
    J Immunol; 2003 May; 170(9):4802-9. PubMed ID: 12707362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
    Lees JR; Iwakura Y; Russell JH
    J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-4 producing CD4+ TCR alpha beta int liver lymphocytes: influence of thymus, beta 2-microglobulin and NK1.1 expression.
    Emoto M; Emoto Y; Kaufmann SH
    Int Immunol; 1995 Nov; 7(11):1729-39. PubMed ID: 8580071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the antigen specificity and TCR repertoire, and TCR-based DNA vaccine therapy in myelin basic protein-induced autoimmune encephalomyelitis in DA rats.
    Miyakoshi A; Yoon WK; Jee Y; Matsumoto Y
    J Immunol; 2003 Jun; 170(12):6371-8. PubMed ID: 12794171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus.
    Zeng D; Gazit G; Dejbakhsh-Jones S; Balk SP; Snapper S; Taniguchi M; Strober S
    J Immunol; 1999 Nov; 163(10):5338-45. PubMed ID: 10553057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.